global vertigo market is expected to be driven by factors such as rising incidence. For more mail: vikas@konceptanalytics.com

1. Global Vertigo Market:
Industry Analysis & Outlook
-----------------------------------------
(2017-2021)
Industry Research by Koncept Analytics
1
November 2017
Globa Vertigo Market: Industry Analysis & Outlook
(2017-2021)

2. Executive Summary
2
Vertigo is a medical condition where a person feels as if they or the objects around them are moving when
they are not. Often it feels like a spinning or swaying movement. This may be associated with nausea,
vomiting, sweating, or difficulties walking. It is typically worsened when the head is moved. Vertigo is the
most common type of dizziness. The causes for vertigo can be divided into two categories: Peripheral and
Central. Peripheral is linked to the inner ear whereas central is linked to problems in Central Nervous System.
Peripheral vertigo can be further segmented into five major categories: Benign paroxysmal positional vertigo
(BPPV), Acute Unilateral Vestibulopathy, Meniere’s Disease and Vestibular Schwannoma. Amongst all the
stated indication, Meniere’s disease represents the largest growth opportunity for the market players with its
continuously rising incidence.
Growth of global vertigo market is expected to be driven by factors such as rising incidence and prevalence of
peripheral etiologies of vertigo, increasing geriatric population, growing healthcare expenditure and improving
disposable income. Further, the market growth could be hindered by side effects of currently prescribed
medication, the high cost of treatment and tedious drug approval process. The key trends for the market
include extensive research & development and different approaches being adopted by drug manufacturers in
order to target vertigo.
A key drug OTIVIDEX, which is currently in third phase of clinical trials and is being developed by Otonomy
Inc., is discussed in the report. The drug is easier to use and provides a higher and sustained concentration of
dexamethasone relative to existing injections. Further, it is anticipated to provide a well-accepted treatment
option for Meniere’s Disease, if successfully developed.
The report “Global Vertigo Market: Industry Analysis & Outlook (2017-2021)” analyzes the development of
this market, with focus on Europe and US regions. The major trends, growth drivers as well as issues being
faced by the market are discussed in detail in this report. The four major players involved in the development
of breakthrough drug therapy for vertigo: Auris Medical Holding AG., Sensorion SA, Otonomy, Inc. and Sound
Pharmaceuticals, Inc. are being profiled along with their key financials and strategies for growth.
Globa Vertigo Market: Industry Analysis & Outlook
(2017-2021)

3. All of the drugs presently available to treat acute vertigo episodes have sedative effects, which impairs central compensation
mechanisms and the patient’s ability to function normally while being treated. Companies have realized the need for an
effective solution and are spending heavily on research and development of a novel therapy in order to reap the first movers
advantage.
3
• In 2016, … million people were recorded to be suffering
from recurrent vertigo crisis and this patient volume is
expected to be recorded at … million in 2021, thereby,
growing at a CAGR of …% from 2016 to 2021.
• By 2021, the global MD patient volume is forecasted to
be recorded at … million, increasing from … million in
2016, depicting an anticipated CAGR of …%, spanning
from 2016 to 2021.
• In 2016, MD accounted for highest volume share of
treatable patients with …% share, followed by BPPV and
acute unilateral vestibulopathy with …% and …%
shares, respectively.
Global Meniere’s Disease Patient Forecast (2016-2021)
Global Recurrent Vestibular Vertigo Patient Forecast (2016-2021)
Global Treatable Vertigo Patient by Indication (2016)
2016 2017 2018 2019 2020 2021
Million
Meniere's Disease
BPPV
Acute Unilateral Vestibulopathy
Vestibular Schwannoma Cases
2016 2017 2018 2019 2020 2021
Million
Globa Vertigo Market: Industry Analysis & Outlook
(2017-2021)

4. The market players indulged in the development of novel therapies to cure vertigo crisis are focusing on different approaches
in terms of mechanism of action of drug.
4
• In 2016, the volume of recurrent vertigo patients was
noted at … million and is expected to be recorded at …
million in 2021, growing at a CAGR of …%, spanning
from 2016 to 2021.
• The US recurrent vestibular vertigo patient volume was
recorded at … million and is expected to reach … million
in year 2021. The patient pool is expected to grow at a
CAGR of …%.
• In Europe, MD accounted for highest share for treatable
patient volume with …%, followed by BPPV and acute
unilateral vestibuloapathy with …% and …% shares,
respectively.
The US Recurrent Vestibular Vertigo Patient Forecast (2016-2021)
Europe Recurrent Vestibular Vertigo Patient Forecast (2016-2021)
Europe Treatable Vertigo Patient by Indication
2016 2017 2018 2019 2020 2021
Million
Meniere's Disease
BPPV
Acute Unilateral Vestibulopathy
Vestibaular Schwannoma
2016 2017 2018 2019 2020 2021
Million
Globa Vertigo Market: Industry Analysis & Outlook
(2017-2021)

5. Koncept Analytics
CS-36, First Floor, Ansal Plaza
Vaishali, Ghaziabad,
U.P. – 201010
T: +91-120-4130959
M: +91-9871694789
vikas@konceptanalytics.com
Contact Us:
www.konceptanalytics.com
This is a licensed product of Koncept Analytics. You cannot reproduce, publish, distribute, publicly display, sell or create
other works from this report or use them in any way for commercial purpose without our prior permission. Further, you
cannot copy this material, by any means (including electronic copies), for distribution to others unless you have purchased
the corporate license of this report.
We believe the sources are reliable, but Koncept Analytics does not warranty the accuracy or completeness of the data. The
data presented in the report is updated at the publication date but is subject to change at subsequent releases. All possible
efforts have been made to ensure accuracy of data. However, investors should not completely rely on the information given
in this report and must make decisions based on their own investment strategy, risk management and capital adequacy.
For Report Purchase Click Below:
http://www.konceptanalytics.com/Researchreport/global-vertigo-market-industry-analysis-
outlook-2017-2021-27471.aspx
Disclaimer